Business & Finance
Pfizer' board approves higher quarterly cash dividend and share repurchase programme
17 December 2018 -

The board of directors of biopharmaceutical company Pfizer Inc (NYSE:PFE) declared the company's 321st consecutive dividend of USD0.36 of its common stock for the first quarter 2019, it reported on Friday.

This new dividend marks a growth of approximately 6% from the prior dividend of USD0.34 per share of its common stock.

Shareholders of record at the close of business as of 1 February 2019 will receive the dividend on 1 March 2019,

Additionally, the board of directors has launched a new USD10bn share repurchase programme,which is in addition to the USD4.9bn remaining under its current authorisation.